Jacqueline B. Kosecoff

Insider Reports History

Reporting-owner location: Mentor, OH
Latest reporting-owner signature: /s/ Sheryl Southwick, Attorney-in-fact
Transaction source note: Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Jacqueline B. Kosecoff

Form 4 holding Director

Alignment Healthcare, Inc.

Security class: Common Stock
Shares / value: 303,963
Estimated value: $6,206,924
Report date: 13 Mar 2026
Price: $20.42
Ownership: Direct

Form 4 holding Director

STERIS plc

Security class: Ordinary Shares
Shares / value: 26,639
Estimated value: $6,167,728
Report date: 13 May 2024
Price: $231.53
Ownership: Indirect

Form 4 holding Director

HOULIHAN LOKEY, INC.

Security class: CLASS A COMMON STOCK
Shares / value: 15,316
Estimated value: $2,469,092
Report date: 22 May 2025
Price: $161.21
Ownership: Direct

Form 4 holding Director

STERIS plc

Security class: Career Restricted Stock Units
Shares / value: 6,988
Estimated value: $1,674,884
Report date: 08 Aug 2024
Price: $239.68
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount

Form 4 holding Director

TRINET GROUP, INC.

Security class: Common Stock
Shares / value: 17,007
Estimated value: $619,565
Report date: 29 May 2026
Price: $36.43
Ownership: By Trust

Form 4 holding Director

GoodRx Holdings, Inc.

Security class: Class A Common Stock
Shares / value: 27,440
Estimated value: $182,202
Report date: 17 Aug 2022
Price: $6.64
Ownership: Direct

Form 4 holding Director

TRINET GROUP, INC.

Security class: Common Stock
Shares / value: 4,735
Estimated value: $172,496
Report date: 29 May 2026
Price: $36.43
Ownership: Direct

Form 4 holding Director

STERIS plc

Security class: Director Stock Option (right to buy)
Shares / value: 1,388
Estimated value: $118,452
Report date: 08 Aug 2024
Price: $85.34
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount

Form 4 holding Director

GoodRx Holdings, Inc.

Security class: Class A Common Stock
Shares / value: 6,138
Estimated value: $40,756
Report date: 17 Aug 2022
Price: $6.64
Ownership: By Trust

Form 4 holding Director

STERIS plc

Security class: Ordinary Shares
Shares / value: 0
Estimated value: $0
Report date: 13 May 2024
Price: $231.53
Ownership: Direct

Insider Reports Filed by Jacqueline B. Kosecoff

4 TNET

TRINET GROUP, INC.

Report period: 28 May 2026
Transactions: 3
Transaction value: $0
Accepted by SEC: 01 Jun 2026, 18:00
Role: Director
Next action: Open filing details

4 ALHC

Alignment Healthcare, Inc.

Report period: 13 Mar 2026
Transactions: 1
Transaction value: $0
Accepted by SEC: 17 Mar 2026, 16:55
Role: Director
Next action: Open filing details

4 TNET

TRINET GROUP, INC.

Report period: 23 May 2025
Transactions: 3
Transaction value: $0
Accepted by SEC: 28 May 2025, 18:38
Role: Director
Next action: Open filing details

4 HLI

HOULIHAN LOKEY, INC.

Report period: 22 May 2025
Transactions: 1
Transaction value: $0
Accepted by SEC: 23 May 2025, 16:33
Role: Director
Next action: Open filing details

4 ALHC

Alignment Healthcare, Inc.

Report period: 13 Mar 2025
Transactions: 1
Transaction value: $0
Accepted by SEC: 17 Mar 2025, 18:10
Role: Director
Next action: Open filing details

4 STE

STERIS plc

Report period: 08 Aug 2024
Transactions: 3
Transaction value: +$105,939
Accepted by SEC: 12 Aug 2024, 16:35
Role: Director
Next action: Open filing details

4 TNET

TRINET GROUP, INC.

Report period: 24 May 2024
Transactions: 3
Transaction value: $0
Accepted by SEC: 29 May 2024, 18:36
Role: Director
Next action: Open filing details

4 HLI

HOULIHAN LOKEY, INC.

Report period: 23 May 2024
Transactions: 1
Transaction value: $0
Accepted by SEC: 24 May 2024, 16:59
Role: Director
Next action: Open filing details

4 STE

STERIS plc

Report period: 13 May 2024
Transactions: 3
Transaction value: -$825,120
Accepted by SEC: 15 May 2024, 16:39
Role: Director
Next action: Open filing details

4 ALHC

Alignment Healthcare, Inc.

Report period: 13 Mar 2024
Transactions: 1
Transaction value: $0
Accepted by SEC: 15 Mar 2024, 20:00
Role: Director
Next action: Open filing details

4/A TNET

TRINET GROUP, INC.

Report period: 31 Aug 2023
Transactions: 1
Transaction value: -$118,556
Accepted by SEC: 08 Sep 2023, 18:40
Role: Director
Next action: Open filing details

4 STE

STERIS plc

Report period: 03 Aug 2023
Transactions: 4
Transaction value: +$102,106
Accepted by SEC: 07 Aug 2023, 16:35
Role: Director
Next action: Open filing details

4 TNET

TRINET GROUP, INC.

Report period: 31 May 2023
Transactions: 2
Transaction value: $0
Accepted by SEC: 02 Jun 2023, 17:09
Role: Director
Next action: Open filing details

4 HLI

HOULIHAN LOKEY, INC.

Report period: 24 May 2023
Transactions: 1
Transaction value: $0
Accepted by SEC: 25 May 2023, 19:10
Role: Director
Next action: Open filing details

4 STE

STERIS plc

Report period: 15 May 2023
Transactions: 3
Transaction value: -$785,356
Accepted by SEC: 16 May 2023, 16:35
Role: Director
Next action: Open filing details

4 TNET

TRINET GROUP, INC.

Report period: 23 Mar 2023
Transactions: 1
Transaction value: $0
Accepted by SEC: 27 Mar 2023, 18:29
Role: Director
Next action: Open filing details

4 ALHC

Alignment Healthcare, Inc.

Report period: 08 Mar 2023
Transactions: 1
Transaction value: $0
Accepted by SEC: 10 Mar 2023, 16:00
Role: Director
Next action: Open filing details

5 GDRX

GoodRx Holdings, Inc.

Report period: 31 Dec 2022
Transactions: 2
Transaction value: $0
Accepted by SEC: 13 Feb 2023, 17:06
Role: Director
Next action: Open filing details

4 STE

STERIS plc

Report period: 03 Aug 2022
Transactions: 4
Transaction value: +$102,017
Accepted by SEC: 05 Aug 2022, 16:47
Role: Director
Next action: Open filing details

4 GDRX

GoodRx Holdings, Inc.

Report period: 14 Jun 2022
Transactions: 1
Transaction value: $0
Accepted by SEC: 16 Jun 2022, 16:10
Role: Director
Next action: Open filing details

4 TNET

TRINET GROUP, INC.

Report period: 02 Jun 2022
Transactions: 2
Transaction value: $0
Accepted by SEC: 14 Dec 2022, 17:26
Role: Director
Next action: Open filing details

4 HLI

HOULIHAN LOKEY, INC.

Report period: 27 May 2022
Transactions: 1
Transaction value: $0
Accepted by SEC: 31 May 2022, 18:39
Role: Director
Next action: Open filing details

4 TNET

TRINET GROUP, INC.

Report period: 24 Mar 2022
Transactions: 1
Transaction value: $0
Accepted by SEC: 28 Mar 2022, 18:59
Role: Director
Next action: Open filing details

4 ALHC

Alignment Healthcare, Inc.

Report period: 08 Mar 2022
Transactions: 1
Transaction value: $0
Accepted by SEC: 10 Mar 2022, 17:27
Role: Director
Next action: Open filing details

4 STE

STERIS plc

Report period: 10 Feb 2022
Transactions: 3
Transaction value: -$652,739
Accepted by SEC: 14 Feb 2022, 17:38
Role: Director
Next action: Open filing details

5 TNET

TRINET GROUP, INC.

Report period: 31 Dec 2021
Transactions: 2
Transaction value: $0
Accepted by SEC: 19 Jan 2022, 17:00
Role: Director
Next action: Open filing details

4 STE

STERIS plc

Report period: 10 Aug 2021
Transactions: 3
Transaction value: +$101,846
Accepted by SEC: 12 Aug 2021, 16:36
Role: Director
Next action: Open filing details

4 GDRX

GoodRx Holdings, Inc.

Report period: 10 Jun 2021
Transactions: 1
Transaction value: $0
Accepted by SEC: 14 Jun 2021, 16:45
Role: Director
Next action: Open filing details

4 HLI

HOULIHAN LOKEY, INC.

Report period: 26 May 2021
Transactions: 1
Transaction value: $0
Accepted by SEC: 28 May 2021, 16:49
Role: Director
Next action: Open filing details

4 STE

STERIS plc

Report period: 21 May 2021
Transactions: 3
Transaction value: -$502,419
Accepted by SEC: 24 May 2021, 16:33
Role: Director
Next action: Open filing details

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .